Jump to main content.


Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment (External Review Draft 2005)

Note: EPA has updated this document, but this version is provided as a courtesy to the public as a matter of public record.


Contact
Chad M. Thompson
by phone at:   703-347-8907
by email at:  thompson.chad@epa.gov

Notice

Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment (EPA/600/R-05/043A), is an external review draft report. EPA is releasing this report on 7/28/2005 for public review and comment. The public comment period has been extended until 10/14/2005 and written comments should be sent to EPA by this date, as indicated in the August 22 Federal Register Notice. More information about the external peer review workshop from Nov 10-11, 2005 can be found in the October 14 Federal Register Notice.

Comments may be submitted and viewed using EPA's electronic docket (edocket) at www.epa.gov/edocket. Select search and key in the Docket Number ORD-2005-0022 for the document, Approaches for the Application of Physiologically based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment.

This draft report of Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment (PDF, 110pp, 1MB, About PDF) addresses the application and evaluation of PBPK models for risk assessment purposes. These models represent an important class of dosimetry models that are useful for predicting internal dose at target organs for risk assessment applications.

Topics covered include:In addition, appendices are provided that include
Background

History/Chronology

2003EPA award releases a solicitation for a contract to develop a report for the Application of Physiologically Based Pharmacokinetic Data and Models in Risk Assessment
2004Draft document released for internal review
2005EPA released the external review draft for public comment and peer review

Next Steps

In summer 2005, there will be a meeting in Washington, DC for the purpose of providing an independent scientific peer review of this document. EPA will issue a separate notice, to be published in the Federal Register, that will give the dates and place of this public meeting. The notice will describe procedures for the public to register, without cost, to attend the meeting and to give written and/or oral comment before the peer review panel. With the completion of the scientific peer review, EPA will review all comments received, including public comments, to finalize the document.

Then the final report, which addresses both public and peer review comments, will be published and available from the NCEA Web site.

Downloads/Related Links

This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.

Related Link(s)

Citation

Approaches for the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data in Risk Assessment (External Review Draft 2005). U.S. Environmental Protection Agency, Washington, D.C., EPA/600/R-05/043A. 2005.
Email a link to this page to a friend

ORD Home | Search EPA


Local Navigation


Jump to main content.